An NCI-designated Comprehensive Cancer Center

Farah R. Abdulla, M.D.

Dermatopathologist; Dermatologist
Clinical Expertise
  • Cutaneous lymphoma
  • Graft-versus-host disease
  • Skin manifestations and side effects of cancer and cancer therapies
Interim Chief, Division of Dermatology; Assistant Clinical Professor, Division of Dermatology, Department of Surgery

Clinical Teams

  • Cutaneous Lymphoma Program
  • Dermatology
"I chose to work at City of Hope because it is a center that offers what is best today and continues to look what could make for a better tomorrow.”
Farah R. Abdulla, M.D., is that rare individual who chooses to go where others don't. As a dermatologist and dermatopathologist, Dr. Abdulla specializes in the research and treatment of cutaneous lymphoma, a rare form of non-Hodgkin's lymphoma that affects the skin.

Because so few people develop cutaneous lymphoma, it's considered an “orphan” disease with relatively few Food and Drug Administration-approved agents to treat it. Dr. Abdulla is determined to change that. “I want patients who suffer from this disease to have hope,” she says.

Dr. Abdulla earned her medical degree at Northeast Ohio Medical University and continued her training at University of Cincinnati and Stanford University.

Before joining City of Hope, Dr. Abdulla directed the Multidisciplinary Cutaneous Lymphoma Clinic at University of Chicago Medical Center. She's also lent her expertise to the U.S. Department of Defense and the American Association for the Advancement of Science, the world's largest general scientific society.

Dr. Abdulla is engaged in numerous clinical trials, and she's the author of dozens of peer-reviewed papers. She sees City of Hope as an ideal place to fulfill her “responsibility for those who suffer from medical disease and trauma.”


City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

  • Martinez XU, Di Raimondo C, Abdulla FR, Zain J, Rosen ST, Querfeld C. Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sezary syndrome. Best Pract Res Clin Haematol. 2019;32(3):239-52.
  • Jothishankar B, Venkataraman G, Goldberg RC, Abdulla FHeterogeneity of T-cell receptor expression at transformation in mycosis fungoides/Sezary Syndrome (MF/SS). Ann Diagn Pathol. 2019;43:151404.
  • Jothishankar B, Almazan T, Kim Y, Liauw S, Smith S, Kline J, Abdulla FRomidepsin and total skin electron beam therapy in advanced stage mycosis fungoides and Sezary syndrome. Br J Haematol. 2019;186(2):377-9.
  • Di Raimondo C, Abdulla FR, Zain J, Querfeld C, Rosen ST. Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B-cell lymphoma, leg type. Br J Haematol. 2019;187(3):e79-e82.
  • Janiga J, Kentley J, Nabhan C, Abdulla FCurrent systemic therapeutic options for advanced mycosis fungoides and Sezary syndrome. Leuk Lymphoma. 2018;59(3):562-77.
  • Hussain A, Jenkins A, Feneran A, Abdulla FNew-onset acrokeratoelastoidosis in an immunosuppressed patient. JAAD Case Rep. 2018;4(1):75-6.
  • Folkes AS, Feng M, Zain JM, Abdulla F, Rosen ST, Querfeld C. Targeting CD47 as a cancer therapeutic strategy: the cutaneous T-cell lymphoma experience. Curr Opin Oncol. 2018;30(5):332-7.
  • Covington M, Cassarino D, Abdulla FALK Expression is a Rare Finding in Mycosis Fungoides. Am J Dermatopathol. 2017;39(5):342-3.
  • Que SK, DeFelice T, Abdulla FR, Cassarino D, Patel RR. Non-HIV-related Kaposi sarcoma in 2 Hispanic patients arising in the setting of chronic venous insufficiency. Cutis. 2015;95(6):E30-3.
  • Martires KJ, Ra S, Abdulla F, Cassarino DS. Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders. Am J Dermatopathol. 2015;37(11):822-33.
  • Abdulla FR, Sarpa H, Cassarino D. The expression of ALK in mycosis fungoides, stage IA. J Cutan Pathol. 2013;40(3):348-50.
  • Kim YH, Gratzinger D, Harrison C, Brody JD, Czerwinski DK, Ai WZ, Morales A, Abdulla F, Xing L, Navi D, Tibshirani RJ, Advani RH, Lingala B, Shah S, Hoppe RT, Levy R. In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. Blood. 2012;119(2):355-63.
  • Bashey S, Krathen M, Abdulla F, Sundram U, Kim YH. Romidepsin is effective in subcutaneous panniculitis-like T-cell lymphoma. J Clin Oncol. 2012;30(24):e221-5.
  • Abdulla FR, Mutasim DF. Multiple benign lichenoid keratoses. J Am Acad Dermatol. 2010;62(5):900-1.
  • Abdulla FR, Kerns MJ, Mutasim DF. Amelanotic lentigo maligna: a report of three cases and review of the literature. J Am Acad Dermatol. 2010;62(5):857-60.
  • Abdulla FR, Breneman C, Adams B, Breneman D. Standards for genital protection in phototherapy units. J Am Acad Dermatol. 2010;62(2):223-6.
  • Abdulla F, Sheth AP, Lucky AW. Hemorrhagic, bullous Henoch Schonlein purpura in a 16-year-old girl with previously undiagnosed dominant dystrophic epidermolysis bullosa. Pediatr Dermatol. 2010;27(2):203-4.
  • Hawayek LH, Abdulla FRCutaneous abdominal nodule after cesarean delivery. Am Fam Physician. 2009;80(12):1483.
  • Abdulla FR, Sheth PB. A case of perforating necrobiosis lipoidica in an African American female. Dermatol Online J. 2008;14(7):10.
  • Abdulla FR, Adams BB. Ortho-phthalaldehyde causing facial stains after cystoscopy. Arch Dermatol. 2007;143(5):670.
  • Abdulla FR, Feldman SR, Williford PM, Krowchuk D, Kaur M. Tanning and skin cancer. Pediatr Dermatol. 2005;22(6):501-12.
  • Abdulla FR, Brodell RT. Seborrheic dermatitis. The link between facial rash and neurologic disease. Postgrad Med. 2005;117(3):43-4.

Book Chapters

  • Abdulla FR, Duvic M, Kim YH. Chapter 10: Cutaneous T-cell Lymphomas. T-cell Lymphomas (pp 155-78). New York, NY. Springer.
  • Abdulla FR, Harrison C, Kim YH. Chapter 49: Therapeutics in Cutaneous T-cell Lymphoma. Evidence Based Dermatology 2nd Edition. New York, NY. People’s Medical Publishing House.
In The News
An Expert's Voice
CAT scan of man and woman nurse - large hi res

As cancer screenings plummet,
physicians urge vigilance

Farah Abdulla | City of Hope

Meet Our Doctors: Farah Abdulla, M.D.